This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
40,67 €
Share price
0.00%
Change (1 day)
119.76%
Change (1 year)
Categories
Albireo Pharma (ALBO) Fails to deliver data
Key failure to deliver metrics for Albireo Pharma:
- Last SEC data release: 2024-01-31
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: N/A
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Albireo Pharma (ALBO) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Albireo Pharma (ALBO) - since 2016
Volume in USD (price x number of shares), data since 2016Albireo Pharma (ALBO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | €0.94 M | -96.36% |
| 2022 | €26.09 M | 1525.43% |
| 2021 | €1.6 M | -37.84% |
| 2020 | €2.58 M | -14.92% |
| 2019 | €3.03 M | -14.99% |
| 2018 | €3.57 M | -66.14% |
| 2017 | €10.54 M | 3225.05% |
| 2016 | €0.31 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | €4.44 M | €8.8 M | 🇺🇸 USA |